Equol is a metabolite of isoflavone daidzein and has an affinity to estrogen receptors.
Although equol is produced by intestinal bacteria, the association between the status of …

Objective: Equol is an active metabolite of isoflavones produced by gut microbiota. It is
beneficial to health; however, equol-producing ability varies greatly among individuals …

Soy isoflavones have received considerable attention. Individuals with isoflavones‐rich diets
have significantly lower occurrences of cardiovascular disease, osteoporosis, and some …

Only about one third of humans possess a microbiota capable of transforming the dietary
isoflavone daidzein into equol. Little is known about the dietary and physiological factors …

The intestinal microbial transformation of daidzein, one of the principal isoflavones from soy,
into the isoflavan equol is subjected to a high interindividual variability. The latter compound …

Equol, a microbial metabolite of daidzein, has been hypothesized as a clue to the
effectiveness of soy and its isoflavones but is excreted by only 33% of Caucasians. Microbial …

Human health benefits are expected of the anti-estrogenic or estrogenic effects of soy
isoflavone. Recently, the biological effects of one of the metabolites of soy isoflavone, equol …

Epidemiological data suggest that regular intake of isoflavones from soy reduces the
incidence of estrogen-dependent and aging-associated disorders, such as menopause …

Intestinal conversion of the isoflavone daidzein to the bioactive equol is exclusively
catalyzed by gut bacteria, but a direct role in equol formation under in vivo conditions has …

The intestinal microbial transformation of daidzein into equol is subject to a wide inter-
individual variability. The aim of this study was to investigate in vitro this transformation and …